Skip to main content
Livermore
Livermore
ZHEN

Amundi

SEC CIK
0001330387
Latest filing
Aug 26, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q2 2021
Holdings of APLS by Amundi, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−30,721−100.0%Sold outHolders
Q1 202630,721$1.24M<0.1%00.0%UnchangedHolders
Q4 202530,721$771.7K<0.1%−1,462,957−97.9%ReducedHolders
Q3 20251,493,678$36.4M<0.1%−110,427−6.9%ReducedHolders
Q2 20251,604,105$28.6M<0.1%+1,274,523+386.7%AddedHolders
Q1 2025329,582$7.42M<0.1%00.0%UnchangedHolders
Q4 2024329,582$10.9M<0.1%+326,604+10,967.2%AddedHolders
Q3 20242,978$81.6K<0.1%+2,978NewHolders
Q2 20240$00.0%−248,483−100.0%Sold outHolders
Q1 2024248,483$11.8M<0.1%+7,112+2.9%AddedHolders
Q4 2023241,371$17.5M<0.1%−37,593−13.5%ReducedHolders
Q3 2023278,964$13.5M<0.1%+242,860+672.7%AddedHolders
Q2 202336,104$3.22M<0.1%−769−2.1%ReducedHolders
Q1 202336,873$2.85M<0.1%+11,035+42.7%AddedHolders
Q4 202225,838$1.29M<0.1%−4,570−15.0%ReducedHolders
Q3 202230,408$1.75M<0.1%+26,485+675.1%AddedHolders
Q2 20223,923$178.0K<0.1%00.0%UnchangedHolders
Q1 20223,923$221.0K<0.1%00.0%UnchangedHolders
Q4 20213,923$160.0K<0.1%00.0%UnchangedHolders
Q3 20213,923$129.0K<0.1%00.0%UnchangedHolders
Q2 20213,923$248.0K<0.1%–No prior filingHolders